ACB

Aphria Q3 2019 Earnings Review – Headlines Create Opportunity

April 15, 2019

Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.

April 15, 2019

Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.

April 12, 2019

Like most licensed producers in Canada, Aurora Cannabis Inc. (NYSE: ACB; TSX: ACB; Frankfurt: 21P) is currently placing a major focus…

April 8, 2019

Confused about which marijuana stocks are worth your money? The Canadian Cannabis Scorecard is your guide to separating the best…

April 4, 2019

Seeking to expand with additional investment opportunities in the cannabis industry, Aurora Cannabis Inc. (NYSE: ACB; TSX: ACB) just added a…

March 18, 2019

Bottom Line This is likely a quarter Tilray's management wants to forget. Revenue of C$20.9 million missed even the low…

March 14, 2019

A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…

March 11, 2019

German pharmacies will now stock Pedanois 5/1 cannabis oil supplied by Aurora Cannabis Inc. (NYSE: ACB; TSX: ACB; Frankfurt: 21P).

March 7, 2019

As work continues on Phase IV of construction to open a controversial retail shop in the West Edmonton Mall, Aurora Cannabis Inc.…